BioProcess International Announces Winners of the 2016 BioProcess International Awards

Share Article

Eight award winner recipients and twenty-four finalists recognized for bioprocessing achievements during industry gala.

News Image

BioProcess International (BPI), a business-to-business publication, today announced the winners for the 2016 BioProcess International Awards. The awards celebrate the outstanding achievements, collaborations, business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base.

Winners and finalists were honored and recognized by their peers during a very entertaining and exciting awards dinner and ceremony Wednesday evening, 5 October at the Boston Convention and Exhibition Center in Boston, MA.

"The BioProcess International Awards provides the industry with a forum to shine a light on what's really driving progress and advancements in biologics development and manufacturing," said Brian Caine, Co-Founder and Publisher of BioProcess International magazine. "It's the individuals, the collaborations, partnerships, and companies that consistently challenge the industry to never accept what works well as good enough."

Excellence in Leadership
Recognizes any single individual in a company whose leadership skills have allowed them to successfully help their businesses achieve operational excellence.

  •     Winner: Dr. Igor Fisch, Chief Executive Officer, Selexis
  •     Dr. Marcel Bassil, Associate Director, Biotech, Benta SAL
  •     Olivier Loeillot, General Manager, GE Healthcare

Emerging Company
Recognizes the companies to watch! New science, new technologies that have seen significant industry adoption with the chance to change the status-quo.

  •     Winner: NuMedii * Digital Health
  •     Cell and Gene Therapy Catapult * Cell Therapy
  •     Quad Technologies * Cell Therapy

Corporate Citizenship
Recognizes companies that have made unique and significant contributions to the local, regional, and global community.

  •     Winner: GlaxoSmithKline - The PULSE Partnership
  •     Baxter - The Baxter International Foundation
  •     Biogen - Closing the Hemophilia Gap in the Developing World

Excellence in Facility Design or Retrofit
Recognizes a facility that exemplifies innovation through the use of key technologies and/or designs.

  •     Winner: JHL Biotech - Installation of KUBio Biomanufacturing Solution
  •     FujiFilm DioSynth - Re-Purposing a Microbial facility for Multi-Product GMP Manufacturing
  •     Gibraltar Laboratories - cGMP Independent Lab and Sterilization Services

Best Collaboration
Partnerships that have proven to result in significant benefits toward accelerating drug development.

  •     Winner: Puridify/GSK - FibroSelect Industrial Use
  •     G-CON / GEA Pharma Systems / Pfizer: the PCMM Consortium
  •     Pall Life Sciences/FloDesign - Disruptive Cadence Acoustic Separator

Best Technology Application – Upstream
User or supplier of an application that has demonstrated significant adoption, process improvements and documented results.

  •     Winner: Stratophase - Ranger Service
  •     Nova Biomedical - BioProfile FLEX2
  •     Sartorius Stedim Biotech - SAM – Perfusion in an Ambr System

Best Technology Application – Downstream
User or supplier that has been able to demonstrate reduction in downstream processing steps, time, and cost.

  •     Winner: Pall Life Sciences - Cadence Acoustic Separator
  •     Puridify – FibroSelect
  •     Sanofi - Continuous Disposable Technology

Best Technology Application – Analytical
User or supplier has demonstrated increased functionality in novel combinations with other analytical technologies.

  •     Winner: Sciex - High Throughput Glycoslyation Analysis
  •     Catalent Pharma Solutions - Biolayer Interferometry (Octet)
  •     Ovizio - iLine F

BPI’s 2016 Industry Champion

  •     Mark Petrich - Director, Single-Use Systems Engineering, Merck

Congratulations and thank you to all the winners, finalists, and nominees.

About the 2016 BioProcess International Awards Sponsors
GE Healthcare's Life Sciences business provides a wide range of bioprocessing solutions for the development and manufacture of high-quality biotherapeutics and vaccines. Using our expertise, we support our customers in increasing speed to market, while reducing costs and improving performance in drug manufacturing. As a provider of high-quality products, technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.

Pall Life Sciences is the leading global provider of filtration, purification and separation products and technologies to the diverse and rapidly expanding biopharmaceuticals market. These products and technologies are used from the earliest stages of discovery and development of new drugs, through production and delivery of therapies for the prevention, diagnosis and treatment of disease. Our biopharmaceutical products are supported by extensive protocols and technical reports, an industry-leading scientific and technical staff, and worldwide offices and distributors for easy ordering.

JSR Life Sciences is a business unit of JSR Corporation, a global company built on more than 50 years of performance material expertise and it began research in the life sciences field more than 30 years ago.

We are continually developing highly functional materials and products to meet the current and future needs of the growing biotechnology industry. Using a variety of integrated, leading-edge technologies, JSR Life Sciences provides materials that contribute to the manufacturing process of biopharmaceuticals, life science research applications, in vitro diagnostics and medical devices. JSR Life Sciences has offices, laboratories and manufacturing facilities in Tokyo and Tsukuba (JP), Sunnyvale (CA, USA), Leuven (BE), and Beijing (CN).    

Wuxi Biologics. As a premier Contract Discovery, Development and Manufacturing Organization (CDMO), WuXi Biologics provides our clients worldwide with the necessary expertise, quality and capacities to develop biologic drugs from idea to market. Along with our WuXi AppTec affiliates, we provide the world with the ONE true single-source approach that saves our clients critical time and money.

2016 BioProcess International Awards Partners
BioProcess International would like to thank and recognize the following industry partners who help make this event successful
Bio-Process Systems Alliance
Women in Bio
Biotechnology Innovation Organization
Biomanufacturing Training and Education Center

About BioProcess International
BioProcess International (BPI) is a business-to-business publication dedicated to delivering cutting-edge
information focused on the development and manufacture of biopharmaceuticals and therapeutics.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Leah Rosin
Follow >
Visit website